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The generation of a functional nervous system involves a multitude of steps that are controlled by just a few
families of extracellular signaling molecules. Among these, the fibroblast growth factor (FGF) family is partic-
ularly prominent for the remarkable diversity of its functions. FGFs are best known for their roles in the early
steps of patterning of the neural primordium and proliferation of neural progenitors. However, other equally
important functions have emerged more recently, including in the later steps of neuronal migration, axon
navigation, and synaptogenesis. We review here these diverse functions and discuss the mechanisms that
account for this unusual range of activities. FGFs are essential components of most protocols devised to
generate therapeutically important neuronal populations in vitro or to stimulate neuronal repair in vivo.
How FGFs promote the development of the nervous system and maintain its integrity will thus remain an
important focus of research in the future.Introduction
The vertebrate nervous system is without doubt the most
complex organ of the living world, in both morphological organi-
zation and cellular diversity. Understanding how this complexity
is generated is a topic of obvious interest to developmental
biologists, and for neuroscientists it is an important source of
insights into the logic of the organization and function of the
adult brain. Of the many molecules that are implicated in neural
development, fibroblast growth factors (FGFs) may have the
most widespread and best-documented roles in generating
the cellular diversity and morphological complexity of the
nervous system. New functions of FGFs have recently been
discovered and progress has also been made in understanding
the modes of propagation and action of these molecules. The
time is therefore ripe to review these recent developments
alongside better-known functions of FGFs in neural develop-
ment.
The first part of this review will examine succinctly the
diverse components of FGF signaling pathways. For more
detailed information, the reader is directed to several excellent
reviews on this topic (Bo¨ttcher and Niehrs, 2005; Mason, 2007).
The next two sections will discuss the remarkable range of
functions that FGFs serve in proliferating progenitors and in
differentiating neurons, respectively. The fourth section will
then consider the multiple connections of FGFs with disease,
including the direct implication of particular FGFs in human
pathologies and the use of FGFs to generate cells of potential
therapeutic use. Because of the vastness of the subject and
the limited space available, we will not attempt to be compre-
hensive. Our aim is to outline the most significant activities ex-
erted by FGFs in the developing nervous system, focusing on
vertebrates, and to identify common threads and unique
features among them.574 Neuron 71, August 25, 2011 ª2011 Elsevier Inc.Molecular Features of FGF Signaling
FGFs and Their Receptors
The first known FGF ligands, FGF1 and FGF2, were purified in
1975 from the brain and pituitary on the basis of their ability to
stimulate the proliferation of mouse fibroblasts. Other FGFs
were then identified as oncogenes or growth factors for other
cell types, and additional family members were later discovered
by their conserved sequences. Sequencing of the human and
mouse genomes revealed a total of 22 Fgf genes in each
species. Fewer Fgfs exist in invertebrates, with two genes in
C. elegans (egl-17 and let-756) and three in Drosophila (branch-
less, pyramus, and thisbe).
Phylogenic and gene location analysis indicate that the human
and mouse FGF families comprise seven subfamilies whose
members share synteny, greater homology, and similar binding
specificities to receptors (Itoh and Ornitz, 2008; Figure 1). Most
FGF family members are classical signaling molecules that are
secreted in the extracellular space, where they bind to heparan
sulfate proteoglycans (HSPGs). They act in an autocrine or para-
crine fashion by interacting with high affinity and different
degrees of specificity, with tyrosine kinase receptors present
at the cell surface. However, a subset of FGFs called
‘‘hormone-like’’ FGFs (including FGF15/19, FGF21, and FGF23)
have reduced heparan-binding affinity and act at a long distance
as endocrine factors to regulate metabolism. A third subset of
FGFs, called intracellular FGFs (including FGF11 to 14), are not
secreted and do not activate FGF receptors but localize to the
nucleus or interact with the intracellular domains of voltage-
gated sodium channels (Itoh and Ornitz, 2008). This review will
focus on the canonical and nuclear FGFs, since they include all
the factors that have been implicated in neural development.
The receptors of the FGFs (FGFRs) form a subfamily of cell
surface receptor tyrosine kinases (RTKs) that includes four
Figure 1. Structure and Phylogeny of FGF Ligands
and Specificity of Their Interactions with FGF
Receptors
The 22 human and mouse FGF ligands can be subdivided
in canonical (cFGFs), intracellular (iFGFs), and hormone-
like (hFGFs) subfamilies (Itoh and Ornitz, 2008). All FGFs
present a heparan sulfate proteoglycan (HSPG) binding
domain and most have a N-terminal signal peptide (SP)
and are secreted via a classical secretory pathway. The
three members of the FGF9 subfamily (FGF9, 16, and 20)
are efficiently secreted but have uncleavable signal
sequences, while the two FGF1 subfamily members (FGF1
and FGF2) lack identifiable signal sequences and are
secreted by noncanonical pathways. The four FGF11-
related factors (FGF11 to 14) are not secreted and do not
activate FGF receptors but localize to the nucleus (Itoh
and Ornitz, 2008).
The family of FGF receptors contains four main members
(FGFR1 to 4). Their extracellular domain is composed of
three Immunoglobulin-like domains (IgGI-IgGIII) involved
in FGF ligand binding, an acid box (AB) domain, and
a HSPG-binding region, which are involved in interaction
of the receptors with extracellular molecules, particularly
HSPGs, and with cell adhesion molecules (CAMs).
Following the transmembrane domain (TM), the intracel-
lular domain harbors a classical split tyrosine kinase
domain (KI, KII), which contains the catalytic activity of the
receptor as well as autophosphorylation sites that interact
with intracellular substrates (see Figure 2). Tissue-specific alternative splicing events encompassing half of IgGIII generate two isoforms, IIIb and IIIc, which have
very different ligand binding specificities (Zhang et al., 2006). FGFR numbers depicted in bold letters indicate high-affinity binding to the ligand in the same line; in
plain letters they indicate intermediate affinity binding, and in italic they indicate lower affinity binding.
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less and breathless), and one in C. elegans (egl-15). They are
single spanning transmembrane proteins, with an extracellular
domain that binds to FGF ligands, heparan sulfate proteogly-
cans, and cell adhesion molecules, and an intracellular domain
that harbours the tyrosine kinase activity of the receptor and
interacts with intracellular substrates and signal transduction
molecules (Bo¨ttcher and Niehrs, 2005) (Figure 1). FGFRs exist
in multiple isoforms, in particular isoforms b and c that are gener-
ated by tissue-specific alternative splicing events and have very
different FGF-binding specificities (Zhang et al., 2006; Figure 1).
However, the specificities of FGF ligand-receptor interactions
have been established in a cell culture assay, and since these
interactions are strongly influenced by cofactors such as
HSPGs, they may differ substantially in an in vivo context.
Signal Transduction Pathways Downstream of FGFRs
Binding of FGFs to FGFRs triggers receptor dimerization and
tyrosine kinase activation, resulting in autophosphorylation of
the intracellular domain of the receptor and recruitment and
assembly of signaling complexes. Multiple pathways have
been shown to operate downstream of FGFRs (Figure 2). Briefly,
theMAPK/Erk signaling cascade is the pathwaymost commonly
employed by FGFRs and results in stimulation of the expression
and/or activation of various transcription factors that act as
effectors of the pathway, including Ets proteins, AP1, GATA
proteins, c-myc, and CREB (Yordy and Muise-Helmericks,
2000), and in the induction of multiple feedback inhibitors
including Sef, MKP3, and Sproutys (Figure 2; see below). The
MAPK/Erk pathway is particularly important in mediating the
proliferative activity of FGFs. Activation of a second pathway,
the PLCg/Ca2+ pathway, has been implicated in the stimulation
of neurite outgrowth by FGF2 (Doherty and Walsh, 1996). ThePI3 kinase/Akt pathway mediates some of the activities of
FGFs in other tissues but there is little evidence for its role in
neural development in vivo downstream of FGFRs. An additional
transduction pathway involving the docking proteins FRS2 a and
b and the small GTPases Rnd1 and RhoA has been shown to
mediate the effect of FGF signaling on cytoskeletal rearrange-
ments and neurite outgrowth in PC12 cells (Harada et al., 2005).
Feedback Loops and Other Regulatory Mechanisms
FGF signaling is regulated at multiple levels, resulting in a tight
control of its level, its spread, and its timing. Some of the mech-
anisms involved are specific to FGF signaling while others
regulate RTK signaling in general. Interaction of FGFs and their
receptors with heparan sulfate proteoglycans (HSPGs) in the
extracellular space is central to FGF signaling, as HSPGs are
required both for high-affinity binding of FGFs to their receptors
and for the bridging of the two subunits of FGFR dimers that is
required for their autophosphorylation (Figure 3). Moreover,
HSPGs contribute to the specificity of the interaction between
FGF-FGFR pairs, protect FGFs from degradation, and limit their
diffusion. They represent a highly diverse group of molecules
with complex temporal and spatial expression patterns and
there is accumulating experimental evidence of their importance
in FGF signaling at different stages of neural development
(Grobe et al., 2005; Jen et al., 2009; Sirko et al., 2010; see
Figure 3).
Many of the molecules regulating FGF signaling are them-
selves regulated by FGFs in positive or negative feedback loops.
The transmembrane protein Sef and the intracellular proteins
Sprouty, which inhibit MAPK signaling downstream of FGFRs
by interacting with different components of the pathway, are
part of the Fgf8 synexpression group (i.e., their expression pat-
terns in embryos are similar to that of Fgf8 as a result of theirNeuron 71, August 25, 2011 ª2011 Elsevier Inc. 575
Figure 2. Intracellular Signaling Pathways
Activated Downstream of FGF Receptors
The four pathways operating downstream of activated
FGFRs that are mentioned in the text are illustrated in the
figure. The Ras/MAPK/Erk pathway involves the lipid-
anchored docking protein FRS2, which is constitutively
bound to FGFR1 and becomes phosphorylated upon
FGFR activation. Phosphorylated FRS2 is bound by the
adaptor protein Grb2, resulting in formation of a multi-
protein complex that localizes to the cell membrane and
activates the Ras-MAPK signaling cascade. This cascade
results in transcriptional activation and/or stabilization of
feedback inhibitors and transcriptional effectors of the
pathway. The PI3 kinase/Akt pathway can be activated by
several mechanisms downstream of FGFRs, including the
recruitment of Gab1 by Grb2. Activation of the PLCg/Ca2+
pathway is initiated by recruitment of PLCg to a phos-
phorylated tyrosine of FGFR1. Green cartouches indicate
the main components of the pathways; orange car-
touches, the components that give their names to the
pathways; blue cartouches, the regulators; and yellow
cartouches, the cellular functions of the pathways.
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tance of FGF signaling in brain development, the fine-tuning of
the pathway by Sprouty and Sef is essential for proper brain
morphogenesis (Faedo et al., 2010; Labalette et al., 2011).
Generation of Neural Stem Cells
Neural Induction
The development of the nervous system in vertebrates begins
with the acquisition of a neural fate by the dorsal ectoderm of
the gastrulating embryo, a process known as neural induction.
An early ‘‘default model’’ of neural induction postulated that
induction of neural tissue in Xenopus embryos only requires inhi-
bition of bone morphogenetic protein (BMP) signaling, which
counters the intrinsic tendency of ectoderm to adopt a neural
fate. However, it is now clear that FGF signaling also has a crucial
role in neural induction in amphibians, fish, and birds (Delaune
et al., 2005; Kudoh et al., 2004; Rentzsch et al., 2004; Stern,
2005). FGFs act in part by antagonizing BMP signaling through
phosphorylation and inhibition of the BMP effector Smad1 and
direct repression of BMP transcription (Londin et al., 2005;
Pera et al., 2003), but they also act independently of BMP, for
example by inducing the expression of Zic3, a transcription
factor required for neural fate specification in Xenopus embryos
(Marchal et al., 2009). Experiments involving the grafting of cell
pellets or beads releasing growth factors into chick embryos
have provided evidence that FGFs act at multiple steps during
neural induction in this model, initiating expression of markers
of a ‘‘preneural state’’ on their own, but acting in combination
with Wnt- and BMP-antagonists to induce additional neural
markers (Albazerchi and Stern, 2007). In the ascidian sea squirt,
FGFs rather than BMP inhibitors are the main inducers of neural
cell fates (Bertrand et al., 2003).
Neural Plate Patterning
Neural induction is intimately linked to the subsequent step of
neural plate patterning, as cells of the neural plate simulta-576 Neuron 71, August 25, 2011 ª2011 Elsevier Inc.neously acquire their neural fate and their posi-
tional information. FGFs, produced in gastrulat-
ing mouse embryos by the node and theprimitive streak and later by the posterior neural plate, have
been implicated, together with Wnt and retinoic acid (RA), in
the specification of posterior neural fates, either directly or by
posteriorization of the caudal plate (Bel-Vialar et al., 2002; Kudoh
et al., 2004; Rentzsch et al., 2004; Stern, 2005; Takemoto et al.,
2006). Exposure of chick embryos or mouse neural plate
explants to FGFs at increasing concentrations or for increasing
durations induces progressively more posterior fates, marked
by the expression of different Hox and Cdx genes, resulting in
the specification of motor neuron pools of different anterior-
posterior identity (Liu et al., 2001).
FGFs also have a major role in induction and patterning of the
peripheral nervous system, which develops from the neural crest
in the trunk of the embryo and from both ectodermal placodes
and the neural crest in the head (McCabe and Bronner-Fraser,
2009; Streit, 2007). FGFs act at multiple stages, first initiating
the formation of a ‘‘border region’’ surrounding the neural plate,
where different levels of BMP and Wnt signals determine
whether cells adopt a neural crest or a placode fate. FGF signals
are then required again for the induction of the different placo-
des; FGF3 and FGF8 induce the otic placode that gives rise to
the inner ear and the epibranchial placodes that generate cranial
ganglia, while FGF8 induces the olfactory placode, which
develops into the olfactory sensory epithelium. The outstanding
question of how the same FGF signals induce distinct placodes
at different locations is being actively investigated.
Regionalization of the Neural Primordium
After the induction and initial patterning of the neural plate during
gastrulation, the positional identities of cells along the antero-
posterior axis of the neural plate are refined and maintained by
several local organizing centers, which influence the fate,
growth, and organization of adjacent tissues in a position-
specific manner by emitting secreted signaling molecules. FGF
signaling is a common feature of the activity of most neural plate
Figure 3. Ternary Complexes Comprising FGFs,
FGFRs, and Heparan Sulfate Proteoglycans
(A) Tridimensional structure of a 2:2:2 dimeric ternary
complex between FGF2 (orange), FGFR1 (blue), and the
heparan sulfate moiety of a heparan sulfate proteoglycan
(HSPG) (white). Reproduced from Schlessinger et al.
(2000).
(B) Molecular surface representation of the same dimeric
ternary complex. Reproduced from Schlessinger et al.
(2000).
(C) HSPGs are essential for the assembly of the FGF-
FGFR complex, as their negative charges create binding
sites for both FGF and FGFR. Regulation of HSPG
synthesis can therefore modulate FGF signaling exten-
sively. Twenty-six enzymes are responsible for the
assembly of heparan sulfate chains. For example, Ndst1
catalyzes the first sulfation step during heparan sulfate
synthesis and Ndst1 mutant embryos present defects in
telencephalic development that are similar to those of Fgf8
mutant embryos (Grobe et al., 2005). Enzymes that cleave
heparan sulfate chains (heparanases) or remove the
sulfates (sulfatases) have also been shown to modulate
FGF signaling.
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anterior forebrain, the zona limitans intrathalamica in the thal-
amus, the isthmic organizer at the boundary between the
prospective midbrain and hindbrain, and the organizer in rhom-
bomere 4 of the hindbrain (Rhinn et al., 2006; Figure 4). The
isthmic organizer produces several FGFs, including two splicing
isoforms of FGF8 (FGF8a and FGF8b), FGF17, and FGF18, which
collectively orchestrate the development of the midbrain anteri-
orly and the cerebellum posteriorly. Culture of mouse brain
explants with FGF-soaked beads and misexpression of FGFs
in the brain of chick embryos have revealed that FGF8a,
FGF17, and FGF18 promotemidbrain development by activating
low to medium levels of FGFR signaling, while FGF8b induces
a cerebellar fate by eliciting higher levels of signaling because
of its higher affinity toward the c isoform of FGFR3 (Liu et al.,
2003; Olsen et al., 2006; Sato et al., 2001; Figure 4A). Once the
hindbrain andmidbrain have been specified, isthmic FGF ligands
become involved in the generation of specific types of neurons in
these two brain regions. Treatment of rat explants from different
regions of the neural plate with various combinations of growth
factors and blocking antibodies showed that FGFs specify
noradrenergic and serotoninergic neurons in the hindbrain and
dopaminergic neurons in the midbrain, by interacting with
signals that pattern the neural tube along the dorso-ventral
axis, including BMPs and Sonic Hedgehog (Shh) (Partanen,
2007; Ye et al., 1998).
The sequential involvement of FGF signals in multiple steps of
development of the same territory is a recurrent theme in brain
development, best exemplified by the development of the fore-
brain. Fgf8 is initially expressed by the rostral signaling center
located at the anterior margin of the neural plate, and it remains
expressed in this region as the neural plate folds and fuses to
form the telencephalic primordium (Crossley et al., 2001). A
detailed analysis of telencephalic development in mice carrying
various mutant alleles of Fgf8 or ectopically expressing FGF8
showed that this signal initially confers a telencephalic characterto the anterior neural plate, through regulation of the expression
and activity of other signaling molecules including Wnts, BMPs,
and Shh (Shimogori et al., 2004; Storm et al., 2006; Figure 4C).
Deletion of the three Fgfrs expressed in the developing forebrain,
Fgfr1-3, showed that FGF signaling also maintains survival of
telencephalic progenitors (Paek et al., 2009). In addition to this
global role of FGF signaling in telencephalic development, anal-
ysis of embryos with reduced or increased levels of Fgf8 expres-
sion, or lacking Fgfr1 and 2 but retaining Fgfr3, revealed that FGF
signaling also specifies ventral telencephalic fates downstream
of Shh signaling (Gutin et al., 2006; Shinya et al., 2001; Storm
et al., 2006).
Once the dorsal and ventral subdivisions of the telencephalic
vesicles have been established, FGFs remain involved in the
subsequent development of these territories and particularly in
the subdivision of the dorsal cerebral cortex into multiple func-
tional areas that control sensory perception, motor activity,
and behavior in adult organisms. Studies performed in the last
decade have established that cortical areas acquire distinct
molecular identities around the time of birth and that FGF8 and
other FGFs secreted by the rostral signaling center specify ante-
rior cortical areas by regulating the regional expression of mul-
tiple transcription factors in the cortical neuroepithelium (Hoch
et al., 2009; O’Leary and Sahara, 2008). Overexpression of
Fgf8 in the early cortical primordium of mouse embryos results
in amassive expansion of anterior cortex without change in over-
all cortical size and its ectopic expression posteriorly results in
duplication of anterior cortical territory, while reducing FGF8
activity results in contraction of anterior cortical areas (Fuku-
chi-Shimogori and Grove, 2001; Garel et al., 2003). FGF8
patterns the anterior cortex by suppressing in a dose-dependent
manner the anterior expression of Emx2 and CoupTF1, two tran-
scription factors specifying posterior area identities. FGF8 also
activates several transcription factors anteriorly including Sp8,
which maintains the expression of Fgf8 in a positive feedback
loop (Cholfin and Rubenstein, 2008; Garel et al., 2003; O’LearyNeuron 71, August 25, 2011 ª2011 Elsevier Inc. 577
Figure 4. Interactions of FGFs with Other
SignalingMolecules in the Developing Brain
FGF8, FGF17, and FGF18 are coexpressed in the
signaling center of the isthmic organizer between
midbrain and hindbrain (A), the zona limitans in-
trathalamica of the thalamus (B), and the anterior
forebrain (C) from E9.5 to E10.5, with FGF8 playing
the major role as it induces the expression of both
Fgf17 and Fgf18. By E12.5, FGFs pattern the
territories surrounding the signaling centers and
begin to specify the identity of neuronal pop-
ulations, as illustrated at E18.5. FGF signaling (in
orange) induces (red arrows) or represses (blue
arrows) the expression and/or activity of specific
transcription factors and interacts with other
signaling pathways, including Shh (purple), Wnt,
and Bmp (dark blue). Note that the FGF8 and Shh
pathways cooperate in both the mid/hindbrain (A)
and the anterior forebrain (C).
(A) Fgf8 expression at the midbrain/hindbrain
border between E9.5 and E12.5 spans the isthmic
organizer (IsO). Two isoforms of FGF8 have
distinct functions, with FGF8a being involved in
midbrain patterning and FGF8b in induction of the
cerebellum and in specification of dorsal midbrain
neurons. As in the telencephalon, FGF17 patterns
a smaller territory of the midbrain and cerebellum
than FGF8.
(B) In the diencephalon at E10.5, Fgf8 is expressed
near the dorsal midline of the p2 domain while Shh
is expressed in the zona limitans intrathalamica
(zli) at the border between the p2 and p3 domains.
At E12.5, FGF8 patterns the anterior part of the p2
domain (presumptive thalamus) (Kataoka and
Shimogori, 2008).
(C) In the anterior telencephalon at E9.5, Fgf8 is
expressed in the anterior neural ridge (ANR) and
commissural plate (CoP) and it patterns the ante-
rior part of the telencephalon, particularly the
olfactory bulb (OB) and the anterior cortex. FGF8
interacts withWnt/Bmp from the cortical hem (CH)
and Shh from the ventral neural tube, and induces
‘‘anterior’’ transcription factors (e.g., Sp8, Pax6,
Ets) and represses ‘‘posterior’’ factors (Emx2,
CoupTF1). FGF17 patterns a subdomain of the
anterior cortex, while FGF15 counteracts FGF8/17
activities. The functions of FGF signaling in the
ventral telencephalon, e.g., through regulation of
Shh and Nkx2.1, are not illustrated.
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FGF17, which is also secreted by the rostral signaling center,
showed that this FGF has a more restricted role in telencephalic
patterning and specifically controls the size and position of the
dorsal frontal cortex (with important consequences for adult
behavior that are discussed later) without affecting the develop-
ment of the ventral frontal cortex, in contrast with FGF8 which
regulates the size of both territories (Cholfin and Rubenstein,
2007, 2008). The divergent activities of FGF17 and FGF8 likely
reflect spatio-temporal differences in their expression within
the rostral signaling center as well as different affinities for
FGFRs. Analysis of mice null mutant for FGF15, a third FGF
secreted anteriorly, revealed that this factor has a unique role
among telencephalic FGFs as it opposes FGF8 function and
suppresses anterior telencephalic fates, at least in part by578 Neuron 71, August 25, 2011 ª2011 Elsevier Inc.promoting expression of CoupTF1. Addition of FGF8 and
FGF15 to cortical cell cultures differentially activates several
kinases acting downstream of FGFRs, suggesting that the two
ligands interact with different FGFRs (Borello et al., 2008). In
addition to their roles in the specification of areal identities,
FGFs also control the differential growth of cortical subdomains,
as discussed in the next section.
A combination of experiments, including analysis of FGF8
protein distribution, fate mapping of FGF8-expressing cells,
and inhibition of FGF8 signaling with a dominant-negative
version of FGFR3c, has demonstrated that FGF8 acts in the
telencephalon as a classic morphogen. It forms a diffusion
gradient across the entire antero-posterior extent of the
telencephalic primordium and acts directly at a distance from
its source to impart different positional identities at different
Figure 5. Specification of Cajal-Retzius Cell andMorphogen Spread
At E10.5 in the mouse, the anterior signaling center, also known as anterior
neural ridge/commissural plate (ANR/CoP; orange), secretes FGFs while the
telencephalic posterior signaling center or cortical hem (CH; blue) secretes
Wnts and TGFbs. Together, these molecules pattern the ventricular zone (VZ)
of the telencephalon along its anterior-posterior axis (Sur and Rubenstein,
2005). FGF8 and caudal molecules such as TGFbs have been implicated in the
specification of distinct population of the pioneer Cajal-Retzius neurons (Ha-
nashima et al., 2007; Siegenthaler and Miller, 2008; Zimmer et al., 2010). In
addition, Cajal-Retzius cells generated anteriorly and migrating tangentially in
the marginal zone (MZ) have been shown to secrete FGF15 and FGF17 and
thus to participate to the spread of morphogens that pattern the telencephalic
VZ (Griveau et al., 2010). It is unknown whether Cajal-Retzius cells generated
posteriorly in the CH similarly spread Wnt and TGFb signals while migrating in
the MZ.
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by the isthmus produces a concentration gradient that generates
graded patterns of gene expression in the midbrain (Chen et al.,
2009). Direct examination of single molecules of green fluores-
cent protein (GFP)-tagged FGF8 in living zebrafish embryos
showed that FGF8 diffuses in the extracellular space, with its
signaling range being controlled by HSPGs and by receptor-
mediated endocytosis in receiving cells (Yu et al., 2009).
FGF8 produced anteriorly also induces the development of the
telencephalic midline (Okada et al., 2008; Storm et al., 2006) and
the generation of particular neuronal populations, including
a subset of the pioneer Cajal-Retzius neurons (Zimmer et al.,
2010; Figure 5) and gonadotrophin-releasing hormone (GnRH)-
producing neurons. This later population deserves special
mention, as loss-of-function mutations in either Fgf8 or Fgfr1 in
humans produce defects in the specification and the subsequent
steps of axon extension and migration of GnRH neurons, result-
ing in Kallmann syndrome or idiopathic hypogonadotropic hypo-
gonadism, an heterogeneous genetic disorder associated with a
deficit of GnRH production (Dode´ et al., 2003; Falardeau et al.,
2008). The roles of FGFs in axon extension and neuronal migra-
tion are discussed below.
Development of Neural Stem Cells
Proliferation
Once neural progenitors have been generated in the developing
brain and spinal cord, FGFs play important roles in their survival
and expansion (Diez del Corral et al., 2003; Inglis-Broadgate
et al., 2005; Maric et al., 2007; Paek et al., 2009; Storm et al.,
2006, 2003; Vaccarino et al., 1999). The early expansion of the
neural primordium, before neurogenesis begins, involves sym-metric divisions of neuroepithelial cells. At the start of neurogen-
esis, neuroepithelial cells transform into radial glial cells, which
divide asymmetrically to generate another radial glia and a post-
mitotic neuronor anamplifyingprogenitor (foundonly in the telen-
cephalon and termed basal progenitor because it divides away
from the telencephalic ventricle) (Go¨tz and Huttner, 2005).
Studies of mice mutant for different FGFs have revealed that
the FGF family is collectively involved in the progression of
neurogenic lineages at each of these steps. FGF2 and FGF8
maintain the proliferative divisions of neuroepithelial cells before
the onset of neurogenesis (Raballo et al., 2000; Storm et al.,
2006). FGF10 then promotes the maturation of symmetrically
dividing neuroepithelial cells into asymmetrically dividing radial
glia cells and the initiation of neurogenesis (Sahara and O’Leary,
2009). FGF signaling is required again after neurogenesis has
started, to slow down the progression from radial glia to basal
progenitors (Kang et al., 2009).
Several of the FGF ligands and receptors that control telence-
phalic growth are expressed in gradients across the telence-
phalic vesicles and only regulate the size of limited portions of
the cortical primordium. Analysis of mouse embryos carrying
hypomorphic or conditional mutations of Fgf8 has established
that FGF8, secreted by the rostral signaling center, specifically
increases the size of the anterior-ventral telencephalon by stim-
ulating cell proliferation and inhibiting apoptosis (Storm et al.,
2006). The study of FGF15 null mutant mice has shown that
this factor, which is also secreted anteriorly, opposes FGF8
activity and promotes cell-cycle lengthening and cell-cycle exit
in the caudal-ventral cortex, in part by activating the expression
of the transcription factor COUP-TF1 (Borello et al., 2008).
FGFR3, which is expressed in a gradient with highest levels in
the posterior-lateral cortex, has been proposed to control the
growth of this part of the cortex by regulating cell-cycle length
and duration of the neurogenic phase, based on analysis of
mice expressing a constitutively active version of the receptor
(Thomson et al., 2009).
Although FGF10 is uniformly expressed throughout the ante-
rior-posterior axis of the cerebral cortex, loss of Fgf10 results
in excess cell proliferation only in the anterior cortex, suggesting
that other factors with a similar neurogenic activity operate pos-
teriorly (Sahara and O’Leary, 2009). FGF2 has been reported to
be expressed across the whole cortical progenitor zone (also
known as ventricular zone or VZ) of the cortex, as well as being
released by afferent thalamic axons (Dehay et al., 2001), and in
contrast to other FGFs it is required throughout the cortex for
progenitor divisions during early neurogenesis and the subse-
quent generation of appropriate numbers of projection neurons
(Raballo et al., 2000). Analysis of the adult subventricular zone
in mice that are constitutively null mutant for FGF2 or have
been infused with the factor suggests that FGF2 might promote
progenitor proliferation all the way to adult neurogenesis (Wag-
ner et al., 1999; Zheng et al., 2004). Expression of mutated
versions of FGFR1 in adult neural stem cell cultures has impli-
cated the MAPK/Erk pathway in the maintenance of adult stem
cell proliferation and the PLCg/Ca2+ pathway in inhibition of as-
troglial differentiation and maintenance of the neuronal and
oligodendroglial differentiation potential of neural stem cells
(Ma et al., 2009). However, definitive evidence of a role ofNeuron 71, August 25, 2011 ª2011 Elsevier Inc. 579
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tion of the gene) is still lacking, as the null mutation might act
only indirectly during embryonic development, by reducing the
number of founder cells for adult neural stem cells.
FGF2 is also a potent mitogenic factor for telencephalic
progenitors in vitro (Maric et al., 2007), and adding high concen-
trations of both FGF2 and epidermal growth factor (EGF) has
become standard procedure to expand neural stem cells in
floating ‘‘neurosphere’’ or adherent cultures (Conti et al., 2005;
Palmer et al., 1995; Vescovi et al., 1993). In primary cultures of
rodent embryonic telencephalon, FGF2 induces responsiveness
of neural progenitors to EGF, which might account in part for the
synergistic activities of the two factors (Ciccolini and Svendsen,
1998; Lillien and Raphael, 2000). FGF2 promotes the prolifera-
tion of neural progenitors in these cultures by shortening the
G1 phase of the cell cycle and by inhibiting the generation of
postmitotic neurons, via upregulation of cyclin D2 and downre-
gulation of the cyclin-dependent kinase inhibitor p27/kip1
(Lukaszewicz et al., 2002; Maric et al., 2007; Wilcock et al.,
2007). Manipulations of FGF signaling in chick embryo explants
and zebrafish embryos have shown that FGFs also maintain the
progenitor state by opposing the neuronal differentiation activity
of retinoid signaling, e.g., through repression of the RA-synthe-
sizing enzyme Raldh2 by FGF8 in the spinal cord and through
upregulation of the RA-degrading enzyme Cyp26 by FGF20a in
the hindbrain (Diez del Corral et al., 2003; Gonzalez-Quevedo
et al., 2010).
Interestingly, functional analysis of several components of the
MAPK/Erk pathway, including FRS2a, MEK, Erk2, and C/EBPb,
has revealed a crucial role of the pathway not only in the prolifer-
ation but also in the neuronal commitment and differentiation of
cortical progenitors (Me´nard et al., 2002; Paquin et al., 2005;
Samuels et al., 2008; Yamamoto et al., 2005; Figure 2). However,
FGFs and FGFRs themselves have not been widely implicated in
the restriction of multipotent neural progenitors to the neuronal
lineage or their subsequent differentiation, except for the neuro-
genic function of FGF15 in the telencephalon and midbrain
(Borello et al., 2008; Fischer et al., 2011) and a few other
instances of FGF signaling promoting cell-cycle exit and
neuronal differentiation, e.g., in the retina and cranial placodes
(Cai et al., 2010; Lassiter et al., 2009). Whether FGFs or other
growth factors acting via the MAPK/Erk pathway, such as
PDGF or neurotrophins, are the main inducers of neurogenesis
in the cerebral cortex remains an open question.
Gliogenesis
In all vertebrates, neural progenitors generate neurons first and
glial cells later, allowing for the establishment of neuronal
connections and subsequent addition to the nascent circuits of
matching numbers of glial cells. FGF2 induces cortical progeni-
tors to adopt an astroglial fate at the expense of neuronal fates
when added to embryonic cortical cell cultures (Morrow et al.,
2001; Qian et al., 2000). This finding suggests that FGF2,
secreted by cortical neurons, acts on progenitor cells in a nega-
tive feedback loop that brings about the switch from neurogen-
esis to gliogenesis. FGF9, which is also expressed by cortical
neurons, might participate in a similar regulatory loop controlling
the timing of astrogliogenesis in the cortex (Seuntjens et al.,
2009; Figure 6A–6D). FGF promotes astrocyte differentiation in580 Neuron 71, August 25, 2011 ª2011 Elsevier Inc.cortical cultures by instigating changes in histone methylation
at the promoter of the Glial Fibrillary Acidic Protein (GFAP)
gene, which facilitates activation of the promoter by other glio-
genic pathways such as the CNTF-Jak-STAT pathway (Song
and Ghosh, 2004). FGF signaling has also been implicated in
the specification of the other major glial cell type, oligodendro-
cytes. Oligodendrocytes are generated in successive waves by
progenitors located at different dorso-ventral positions in the
neural tube, including ventral progenitors that are specified by
Shh and dorsal progenitors that are induced by a Shh-indepen-
dent process. Manipulations of FGF signaling in mouse, chick,
and zebrafish, both in vitro and in vivo, support a role of the
pathway in the generation of Shh-independent dorsal oligoden-
drocyte progenitors via induction of the oligodendrocyte deter-
minant Olig2 and the oligodendrocyte and astrocyte determinant
Sox9 (Chandran et al., 2003; Esain et al., 2010; Gabay et al.,
2003; Kessaris et al., 2004; Naruse et al., 2006). Interestingly,
the role of FGF signaling in gliogenesis is conserved in
Drosophila, where two FGF8-like ligands, expressed in either
glial cells or neurons and signaling through different FGFR down-
stream pathways, promote the proliferation andmigration of glial
cells, and their differentiation and subsequent wrapping of
axonal processes, respectively (Franzdo´ttir et al., 2009).
Neuronal Circuit Assembly
Neuronal Migration
Migration of newborn neurons is an essential step in themorpho-
genesis of the vertebrate brain and in the formation of neural
circuits. FGF signaling has a prominent role in the migration of
a variety of cell types in the embryo, including neurons. FGF18
is secreted by neurons of the cerebral cortex and it signals
back to cortical progenitors, as shown by the FGF18-dependent
expression of the Ets transcription factors Pea3, Erm, and Er81
by VZ cells (Hasegawa et al., 2004; Figures 6E–6G). Blocking
FGF signaling or the activity of Ets proteins by expressing domi-
nant-negative constructs in the cortical VZ leads to neuronal
migration defects, suggesting that FGF18 mediates a feedback
loop through which neurons that have reached their final position
control the migratory behavior and laminar position of the next
wave of neurons (Hasegawa et al., 2004) (Figures 6E–6G).
FGFs, signaling through FGFR1 and FGFR2, also promote the
translocation of astroglial cells from the VZ to the surface of
the cortex (Smith et al., 2006). In particular, FGFR1 is required
for the migration of astrocytes at the dorsal midline, where
they form a structure (the glial sling) that allows commissural
axons to cross to the contralateral hemisphere. Fgfr1 mutant
mice lack brain commissures, including the corpus callosum
and the hippocampal commissure, and homozygous mutations
of the Fgfr1 gene in humans result in Kallman syndrome with a
similar agenesis of the corpus callosum (Dode´ et al., 2003; Smith
et al., 2006; Tole et al., 2006). The Drosophila FGFR breathless is
also involved in midline glial cell migration and formation of
commissures in the Drosophila embryo (Kla¨mbt et al., 1992). In
the cerebellum, FGF9 secreted by granule neurons signals
through FGFR1 and FGFR2 induces Bergmann glial cells to
adopt a radial morphology that provides a substrate for granule
neuron migration (Lin et al., 2009). FGFs are therefore involved in
multiple feedback mechanisms through which neurons control
Figure 6. FGFs in Feedback Loops between
Cortical Neurons and Progenitors
(A) Subdivisions of the embryonic telencephalon: cortical
plate (CP); intermediate zone (IZ); ventricular zone (VZ).
(B and C) Mice mutant for the transcription factor Sip1
present a premature expression of Fgf9 by CP neurons (B)
and an increase and precocious generation of glial
progenitors (not shown), followed by an enhanced post-
natal astrogliogenesis marked by upregulation of the as-
trocytic marker GFAP (Seuntjens et al., 2009) (C).
(D) FGF9 induces expression of the oligodendroglial
progenitor marker Olig2 in organotypic slice cultures of
embryonic cerebral cortex, suggesting that it participates
in a positive feedback loop whereby CP neurons promote
the specification of VZ progenitors to a glial fate (Seuntjens
et al., 2009).
(E) The expression domains of the FGF receptors FGFR1,
2, and 3 in the telencephalon at E12.5–E13.5 overlap with
distinct gradients.
(F) FGF18 is expressed by mature neurons in the CP and
analysis of Fgf18 mutant mice showed that it induces the
expression of the Ets transcription factors Er81/Etv1,
Pea3/Etv4, and Erm/Etv5 in progenitors of the VZ (Hase-
gawa et al., 2004).
(G) Overexpression of dominant-negative forms of Ets
factors or of FGFR3 in mouse embryonic telencephalon
resulted in migration defects of cortical neurons, sug-
gesting that FGF18 and Ets proteins participate in a
positive feedback loop between CP neurons and VZ
progenitors that promotes the migration of newborn
cortical neurons (Hasegawa et al., 2004).
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in the cerebral cortex and cerebellum.
Axon Pathfinding
Another important step in the assembly of neural circuits, the
directional growth of axons toward their targets, also requires
FGF signaling. FGFs act as target-derived signals that control
the growth, navigation, branching, and target recognition of
axons in multiple brain regions. In particular, FGFs emanating
from signaling centers are in strategic positions to coordinate
axon navigation with other aspects of brain organization. Grafts
of FGF8-soaked beads in embryonic brains or brain explants
have provided evidence that FGF8 produced by the isthmus
acts as a chemoattractant for axons forming the trochlear nerve
in the anterior hindbrain, while it indirectly repels axons from
midbrain dopaminergic neurons by inducing expression of the
chemorepellent Sema3F in the midbrain (Irving et al., 2002; Ya-
mauchi et al., 2009). Analysis of Fgf8 hypomorphic mutant
mice showed that FGF8 similarly controls the formation of axonal
projections between cortical areas in the telencephalon (Huff-
man et al., 2004). FGF signals produced outside the nervous
system also guide embryonic motor axons to their targets. The
transcription factor LHX3 induces expression of Fgfr1 by a partic-Neuular class of spinal motor neurons, resulting in
attraction of their axons to FGF-producing
somites (Shirasaki et al., 2006). In addition to
their guidance role, FGFs also have strong
axon outgrowth and branching activities. FGF2
promotes intersticial branching of cortical pyra-
midal axons in culture by enhancing the pausing
and enlargement of their growth cones, sug-
gesting that it contributes to the formation ofcollateral axon branches during innervation of the cerebral
cortex (Szebenyi et al., 2001). Interestingly, other molecules
than FGFs may promote axon growth by interacting with FGFRs,
as reported for cell adhesion molecules (CAMs) in both
Drosophila and mammalian neuronal cultures (Garcı´a-Alonso
et al., 2000; Saffell et al., 1997). Interactions of FGF signaling
pathways with other signaling mechanisms have not yet been
extensively examined, and they have the potential to greatly
contribute to the diversity and complexity of FGF functions in
axon pathfinding and other steps of neural development.
Synapse Specification
Once axons have reached their targets, synapses are generated
by the coordinated assembly of presynaptic and postsynaptic
structures. FGF22 and the closely related family members
FGF7 and FGF10 are expressed by neurons during the period
when they receive synapses, and they promote synaptogenesis
in chick motoneuron cultures by inducing synaptic vesicle
aggregation in axon terminals (Umemori et al., 2004). Remark-
ably, analysis of synapse formation in the hippocampus of
Fgf22 and Fgf7mutantmice has shown that FGF22 is specifically
required for presynaptic differentiation at glutamatergic (excit-
atory) synapses while FGF7 has a similar role at GABAergicron 71, August 25, 2011 ª2011 Elsevier Inc. 581
Figure 7. FGFs Regulate Synaptogenesis
(A and C) Pyramidal neurons from the CA3 region of the
hippocampus receive excitatory inputs from the dentate
gyrus (DG) and local inhibitory inputs that form synapses in
the stratum radiatum (SR) and stratum lucidum (SL).
(B) Expression patterns of Fgf7 and Fgf22 and their
cognate receptors Fgfr1 and Fgfr2 in the hippocampus.
(D) FGF22 and FGF7 are both present in dendrites of
hippocampal pyramidal neurons but are differentially dis-
tributed in excitatory (red) and inhibitory (blue) synapses,
respectively (Terauchi et al., 2010). Both FGFs act as
presynaptic organizers but FGF22 promotes the organi-
zation of glutamatergic VGLUT1+ excitatory synapses
while FGF7 organizes inhibitory VGAT+ GABAergic syn-
apses. As a result, the differentiation of excitatory or
inhibitory nerve terminals on dendrites of CA3 pyramidal
neurons is specifically impaired in mutants lacking Fgf22
or Fgf7, respectively (Terauchi et al., 2010).
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tion of GFP-tagged molecules into cultured hippocampal neu-
rons showed that FGF22 and FGF7 are specifically targeted to
glutamatergic and GABAergic synapses, respectively. More-
over, exogenous applications of FGF22 or FGF7 cluster glutama-
tergic and GABAergic vesicles to different extents, suggesting
that the specificity of the two factors lies not only in their locali-
zation to different dendritic subdomains on the postsynaptic
side but also in the activation of different signaling pathways
on the presynaptic side (Terauchi et al., 2010). Indeed FGF22
has been shown to interact in vitro with both FGFR1b and
FGFR2b while FGF7 only interacts with FGFR2b, suggesting
that these FGFs control the specificity of presynaptic nerve
terminal-postsynaptic target recognition in part through differen-
tial binding to FGFR isoforms.
FGFs in Disease
Neurological Diseases
Not surprisingly given their widespread involvement in neural
development, FGFs have been associated with multiple neuro-
logical disorders. Postmortem studies have shown that several
FGF ligands and receptors are downregulated in the prefrontal
cortex and hippocampus of patients withmajor depression, sug-
gesting that dysregulation of FGF signaling is involved in the
disease, e.g., by contributing to the atrophy of the hippocampus
and prefrontal cortex reported in depressed patients (Evans
et al., 2004; Riva et al., 2005). A role of FGFs in the action of
antidepressants has also been proposed, based on the findings
that treating patients and rodents with specific serotonin reup-
take inhibitors increases Fgf expression levels in the prefrontal
cortex and other brain regions, and that acute or chronic admin-
istration of FGF2 reduces anxiety and depression-like behaviors
in rats (Evans et al., 2004; Perez et al., 2009; Turner et al., 2008).
FGF2 could contribute to the action of antidepressants by
reversing hippocampal and cortical atrophy as well as through
its mitogenic effect on hippocampal progenitors, since some of
the behavioral effects of antidepressants require the stimulation582 Neuron 71, August 25, 2011 ª2011 Elsevier Inc.of neurogenesis in the adult hippocampus (Du-
man and Monteggia, 2006; Perez et al., 2009;
Zhao et al., 2007). Dysregulation of FGF
signaling during development has also beenproposed to increase vulnerability to neuropsychiatric disorders
such as autism spectrumdisorder (ASD) (Rubenstein, 2010; Vac-
carino et al., 2009). According to this hypothesis, mutations in
autism susceptibility candidate genes might interfere with FGF
signaling and produce defects in brain growth and cortical circuit
formation that predispose affected individuals to the disease.
This hypothesis has received some support from animal studies,
in particular in Fgf17mutantmicewhere patterning defects of the
frontal cortex during development result in specific deficits in
social behaviors and working memory in adults (Scearce-Levie
et al., 2008).
Besides neuropsychiatric disorders and Kallman syndrome
(see above), FGF signaling deficiencies have been implicated
in neurodegenerative diseases, including a progressive spino-
cerebellar ataxia (Laezza et al., 2007; van Swieten et al., 2003)
and Parkinson’s disease (PD). A genetic association between
single-nucleotide polymorphisms in the Fgf20 gene and in-
creased risk of PD has been identified in several large family
studies and has been confirmed in some but not all subsequent
studies (Clarimon et al., 2005; van der Walt et al., 2004; Wang
et al., 2008). Fgf20 is specifically expressed in the substantia
nigra of the midbrain and the cerebellum, where it promotes
survival of substantia nigra dopaminergic neurons, the neurons
most affected in PD (Murase and McKay, 2006). Carriers of
one of the Fgf20 polymorphisms also present diminished verbal
episodic memory and a significantly enlarged hippocampal
volume, suggesting that genetic variations in Fgf20 also modu-
late brain structure and function in healthy subjects (Lemaitre
et al., 2010).
Neuronal Repair
Lesions to the adult nervous system reactivate developmental
processes such as the proliferation and differentiation of progen-
itors present at the site of injury. Members of the FGF family, in
particular FGF2, are strongly involved in neuroprotection and
repair in response to neural tissue damage. Expression of Fgf2
and Fgfr1 is upregulated in glial cells and neural stem cells
after neuronal damage, and analysis of mice mutant for Fgf2 or
Figure 8. FGFs and the In Vitro Generation
of Neurons
FGFs are involved in three distinct steps of the
in vitro generation of neurons from embryonic
stem (ES) cells. First, FGF4 produced endoge-
nously by ES cells promotes the specification of
mouse ES cells along the neuronal and meso-
dermal lineages. Leukemia inhibiting factor (LIF)
blocks FGF4 activity and maintain ES cells in
a self-renewing and undifferentiated state (left
panel). Second, FGF2 increases the efficiency of
generation of multipotent and self-renewing neural
stem (NS) cells from ES cells and in combination
with epidermal growth factor (EGF), it promotes
the rapid expansion of NS cells in adherent or
‘‘neurosphere’’ cultures (center panel). Third,
different FGFs have been used to guide the
differentiation of human ES cells toward different
neuronal subtypes, as described in the text (right
panel).
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eration following epileptic episodes, transient ischemia, or trau-
matic brain injury (Fagel et al., 2009; Yoshimura et al., 2001).
Exogenous FGF2, alone or in combination with other factors
such as brain-derived neurotrophic factor (BDNF) or EGF, also
promotes significant neuronal regeneration following neuronal
loss induced by epilepsy or ischemia or in genetic models of
neurodegenerative diseases such as Huntington’s disease
(HD) (Jin et al., 2005; Nakatomi et al., 2002). FGF2 appears to
enhance the proliferation and differentiation of endogenous
progenitor cells present in the dentate gyrus (e.g., in mice with
hippocampal lesions) and in the subventricular zone (in HD
mice) as well as outside these neurogenic regions. Exogenous
or endogenous FGF2 also has a role in protection against neu-
ronal death, notably in mouse models of neurodegenerative
diseases such as HD or PD (Jin et al., 2005; Timmer et al., 2007).
Generating Neurons in a Dish
The mammalian nervous system has, however, a limited ca-
pacity for self-repair. Efforts are being made to circumvent this
limitation and boost the repair process by transplanting exoge-
nous cells into sites of injury. FGFs can be used to generate,
expand, and differentiate neurons in vitro and therefore have a
major role to play in such cell replacement therapies (Figure 8).
Pluripotent mouse embryonic stem (ES) cells self-renew indef-
initely in culture when exposed to the cytokine leukemia inhibi-
tory factor (LIF), but they can differentiate into neurons under
the influence of endogenous FGF. ES cells produce FGF4,
which, if left unchecked, acts in an autocrine/paracrine manner
to block self-renewal and promote commitment to the meso-
dermal or neural lineages. BMP and BMP signaling inhibitors
can then act downstream of FGF signaling to promote nonneural
and neural fates, respectively (Kunath et al., 2007; Stavridis et al.,
2007). In self-renewing ES cell cultures, LIF/Stat3 signaling
inhibits lineage commitment by blocking the FGF4 signaling
pathway downstream of Erk (Kunath et al., 2007; Figure 8).Neuron 71Exposure to exogenous FGF2, even in
the absence of BMP antagonists, greatly
improves the efficiency with whichmouse
and human ES cell cultures commit toa neural fate and generate neural precursors (Ying et al., 2003;
Zhang et al., 2001). FGF2 converts these cells into neural stem
cells characterized by rapid self-renewing and the potential to
generate neurons, astrocytes, and oligodendrocytes (Figure 8).
This acquired tripotent neural stem cell state, which does not
exist in vivo, results from the induction by FGF2 of multiple
genes, including EGFR and Olig2, which provide high prolifera-
tive capacity and glial differentiation potential to the treated cells
(Gabay et al., 2003; Hack et al., 2004; Laywell et al., 2000; Palmer
et al., 1999; Pollard et al., 2008; Zhang et al., 2001). When trans-
planted into neonatal mouse brains or lesioned adult mouse
brains, FGF2-induced progenitors can integrate into brain tissue
and differentiate into neurons and astrocytes (Rosser et al.,
2000; Zhang et al., 2001). However, their repair capacity in
animal models with acute brain injuries or slowly progressing
neurodegenerative conditions is rather limited. Amore promising
approach is to first differentiate these cells in culture and trans-
plant them afterwards (Rosser et al., 2007). Protocols are thus
being developed to differentiate neural progenitors into medi-
cally relevant cell types and FGFs, which are implicated in the
development of multiple neuronal lineages in the embryo, again
have an important role to play in this step. For example, FGF2,
FGF8, and FGF20 have been used to guide the differentiation
of in vitro expanded human neural stem cells toward spinal
motor neurons, olfactory bulb projection neurons, and midbrain
dopaminergic neurons, respectively (Correia et al., 2008; Eiraku
et al., 2008; Grothe et al., 2004; Jordan et al., 2009). Looking to
the future, there is no doubt that further deepening our under-
standing of the functions of FGFs in neural development will
benefit the quest for effective treatments of neurological
diseases.
Conclusion
This review has surveyed the remarkable functional diversity of
FGFs in the developing nervous system. A striking illustration, August 25, 2011 ª2011 Elsevier Inc. 583
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cesses regulated by isthmic FGFs, including cell survival, prolif-
eration, specification of cell identity, neuronal differentiation, and
axon growth (Partanen, 2007; see above). Multiple mechanisms
contribute to the functional diversity of the FGF signaling system.
Foremost is the vast number of FGF ligands, which elicit diverse
biological responses because of their different affinities for FGF
receptors and HSPGs (Figure 1). The multiple isoforms of the
four FGFRs and the highly complex family of HSPGs, which
are integral components of the FGF ligand-receptor complex,
also have the potential to hugely diversify signaling activities
downstream of FGFs. The activation of FGF receptor complexes
can trigger several signal transduction cascades (Figure 2),
and crosstalk with other pathways, such as the synergistic and
antagonistic interactions with Wnts, EGF, retinoic acid, and
Notch through which FGFs regulate progenitor divisions (Cicco-
lini and Svendsen, 1998; Diez del Corral et al., 2003; Gonzalez-
Quevedo et al., 2010; Israsena et al., 2004; Yoon et al., 2004),
further expands the range of cellular responses to FGFs. In addi-
tion to this multiplicity of signaling mechanisms, the response of
neural tissues to the same FGF signal can also vary across space
and time. For example, different domains of the neural plate
adopt distinct fates when exposed to FGF8. This differential
response is controlled by spatially restricted transcription fac-
tors, including the homeodomain factor Six3, which instructs
FGF8-induced neural plate cells to adopt a forebrain fate, and
the homeodomain protein Irx3, which directs cells exposed to
the same signal to adopt a midbrain fate (Kobayashi et al.,
2002). Such competence factors are likely to play an important
role in the diversification of FGF functions, and elucidating how
they modulate the cellular response to FGF signaling is an
exciting direction for future research.ACKNOWLEDGMENTS
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